Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 88 from CROI 2019
TUESDAY PLENARY SESSION
DENIAL, DOOM, OR DESTINY? RESURGENT STIS IN HIV CARE AND PREVENTION   (ABSTRACT 12)
Jeanne M Marrazzo
University of Alabama, Birmingham, USA
from CROI 2019 on March 5, 2019 8:30 AM-9:30 AM
TUESDAY PLENARY SESSION
INFLAMMATION: TAMING THE FLAMES   (ABSTRACT 13)
Irini Sereti
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2019 on March 5, 2019 8:30 AM-9:30 AM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
HPV VACCINE WITH LEEP DID NOT PREVENT RECURRENT CERVICAL HSIL IN HIV-INFECTED WOMEN   (ABSTRACT 14)
Cindy Firnhaber
University of Colorado Medical Center, Aurora, CO, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
OPTIMAL LUNG CANCER SCREENING CRITERIA AMONG PERSONS LIVING WITH HIV   (ABSTRACT 15)
Subhashini A Sellers
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
HIV IS ASSOCIATED WITH DECREASED BREAST CANCER SURVIVAL: A PROSPECTIVE COHORT STUDY   (ABSTRACT 16)
Katrin Sara Sadigh
Brigham and Women's Hospital, Boston, MA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
LONG-TERM OUTCOMES OF 58 PATIENTS WITH HIV AND KSHV+ MULTICENTRIC CASTLEMAN DISEASE   (ABSTRACT 17)
Ramya Ramaswami
HIV AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
REDUCTION OF KAPOSI SARCOMA–ASSOCIATED HERPESVIRUS LATENCY USING CRISPR-CAS9   (ABSTRACT 18)
For Yue Tso
University of Nebraska - Lincoln, Lincoln, NE, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
THE ROLE OF WILMS' TUMOR 1 IN KAPOSI SARCOMA HERPESVIRUS ONCOGENESIS   (ABSTRACT 19)
Ayana Morales
Weill Cornell Medical College, New York, NY, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
QUANTIFICATION OF KSHV DNA AS A DIAGNOSTIC TEST FOR KAPOSI SARCOMA IN AFRICA   (ABSTRACT 20)
Aggrey Semeere
Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: AIDS MALIGNANCIES AND KSHV
TWO NOVEL POTENTIAL THERAPEUTIC TARGETS IN THE KSHV LIFE CYCLE   (ABSTRACT 21)
Thomas Schulz
Medizinischen Hochschule Hannover, Hannover, Germany
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
RANDOMIZED TRIAL OF RALTEGRAVIR-ART VS EFAVIRENZ-ART WHEN INITIATED DURING PREGNANCY   (ABSTRACT 39)
Mark Mirochnick
Boston University School of Medicine, Hingham, MA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
RCT OF DOLUTEGRAVIR VS EFAVIRENZ-BASED THERAPY INITIATED IN LATE PREGNANCY: DOLPHIN-2   (ABSTRACT 40)
Saye Khoo
University of Liverpool Institute of Translational Medicine, Liverpool, United Kingdom
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
MATERNAL HBV VIREMIA IS ASSOCIATED WITH ADVERSE INFANT OUTCOMES IN HIV/HBV WOMEN   (ABSTRACT 41)
Debika Bhattacharya
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
IMPACT OF IMPROVED NUTRITION/SANITATION ON NEURODEVELOPMENT OF HIV-EXPOSED CHILDREN   (ABSTRACT 42)
Robert Ntozini
Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
UNIQUE IMMUNOLOGICAL AND VIROLOGICAL FEATURES OF EARLY TREATED HIV-INFECTED NEWBORNS   (ABSTRACT 43)
Pilar Garcia Broncano
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
NEONATAL ART < 7 DAYS VS 7-28 DAYS REDUCED TIME TO SUPPRESSION   (ABSTRACT 44)
Sara Dominguez Rodriguez
Fundación Investigación Biomédica Hospital 12 Octubre, Madrid, Spain
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
SAFETY AND PHARMACOKINETICS OF MONOCLONAL ANTIBODY, VRC01LS, IN HIV-EXPOSED NEWBORNS   (ABSTRACT 45)
Elizabeth J McFarland
University of Colorado School of Medicine, Aurora, CO, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: CRITICAL ISSUES IN MATERNAL AND PEDIATRIC HEALTH
BICTEGRAVIR/FTC/TAF SINGLE-TABLET REGIMEN IN ADOLESCENTS & CHILDREN: WEEK 48 RESULTS   (ABSTRACT 46)
Aditya Gaur
St. Jude Children's Research Hospital, Memphis, TN, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
BREAKING BONES IS BAD: INCIDENT FRACTURE AND MORTALITY IN THE HIV OUTPATIENT STUDY   (ABSTRACT 30)
Linda Ann Battalora
Colorado School of Mines, Golden, CO, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
COPD AND THE RISK FOR MYOCARDIAL INFARCTION BY TYPE IN PEOPLE LIVING WITH HIV   (ABSTRACT 31)
Kristina Crothers
University of Washington, Seattle, WA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
SUDDEN CARDIAC DEATH AMONG HIV-INFECTED AND -UNINFECTED VETERANS   (ABSTRACT 32)
Matthew Freiberg
Vanderbilt University School of Medicine, Nashville, TN, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
HIV POST SCD STUDY: 80% HIGHER RATE OF AUTOPSY-DEFINED SUDDEN ARRHYTHMIC DEATH IN HIV   (ABSTRACT 33)
Zian H. Tseng
UCSF, San Francisco, CA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
CABOTEGRAVIR IS NOT ASSOCIATED WITH WEIGHT GAIN IN HIV-NEGATIVE INDIVIDUALS: HPTN 077   (ABSTRACT 34)
Raphael J. Landovitz
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
ASSESSING THE PROBIOTIC EFFECT IN TREATED HIV: RESULTS OF ACTG A5350   (ABSTRACT 35)
Edgar Turner Overton
University of Alabama, Birmingham, AL, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
FACTOR X INHIBITION REDUCES COAGULATION BUT NOT INFLAMMATION IN PERSONS WITH HIV   (ABSTRACT 36)
Jason V Baker
Hennepin Healthcare Research Institute (U of MN), Minneapolis, MN, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NONCOMMUNICABLE DISEASES IN TREATED HIV
SAFETY, TOLERABILITY AND IMMUNOLOGIC ACTIVITY OF RUXOLITINIB ADDED TO SUPPRESSIVE ART   (ABSTRACT 37)
Vincent C. Marconi
School of Medicine, Emory University, Atlanta, GA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
INCIDENT SYPHILIS RATES AND PREDICTORS IN US WOMEN WITH HIV, 2005-2016   (ABSTRACT 47)
Jodie Dionne-Odom
University of Alabama at Birmingham, Birmingham, AL, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
PREPARING FOR PREP IN ENGLAND: PREVALENCE AND INCIDENCE OF HIV AND BACTERIAL STIS   (ABSTRACT 48)
Dana Ogaz
Public Health England, London, United Kingdom
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
EXPANDING TESTING STRATEGIES IN PARIS: A FREE POSTAL COMPREHENSIVE STI TEST KIT   (ABSTRACT 49)
Heloise M Delagreverie
Hôpital Saint Louis - APHP, Paris, France
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
RANDOMIZED CONTROLLED TRIAL OF INTRAUTERINE DEVICE SAFETY IN WOMEN LIVING WITH HIV   (ABSTRACT 50)
Catherine S Todd
FHI360, Durham, NC, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
DOUBLE-DOSE LEVONORGESTREL IMPLANT DOES NOT FULLY OVERCOME INTERACTION WITH EFAVIRENZ   (ABSTRACT 51)
Kimberly K. Scarsi
University of Nebraska, Omaha, NE, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
PHARMACOGENETICS WORSENS AN ADVERSE ANTIRETROVIRAL-HORMONAL CONTRACEPTIVE INTERACTION   (ABSTRACT 52)
David Haas
Vanderbilt University School of Medicine, Nashville, TN, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
POINT-OF-CARE VIRAL LOAD TESTING IMPROVES HIV VIRAL SUPPRESSION AND RETENTION IN CARE   (ABSTRACT 53)
Paul K Drain
University of Washington, Seattle, WA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING
EFFECT OF THE HITS INTERVENTION ON HIV TESTING UPTAKE AMONG MEN IN SOUTH AFRICA   (ABSTRACT 54)
Hae-Young Kim
Africa Health Research Institute, Durban, South Africa
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRATEGIES FOR HIV CURE
TARGETING THE NONCANONICAL NF-ΚB PATHWAY REVERSES SIV LATENCY   (ABSTRACT 22)
Maud Mavigner
Emory University School of Medicine, Atlanta, GA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRATEGIES FOR HIV CURE
NONSUPPRESSIBLE VIREMIA ON ART FROM LARGE CELL CLONES CARRYING INTACT PROVIRUSES   (ABSTRACT 23)
Elias K Halvas
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRATEGIES FOR HIV CURE
EX VIVO AND IN VIVO EDITING OF THE SIV GENOME IN NONHUMAN PRIMATES BY CRISPR-CAS9   (ABSTRACT 24)
Tricia H. Burdo
Temple University School of Medicine, Philadelphia, PA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRATEGIES FOR HIV CURE
DELAYED VIRAL REBOUND DURING ATI AFTER INFUSION OF CCR5 ZFN-TREATED CD4 T CELLS   (ABSTRACT 25)
Pablo Tebas
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRATEGIES FOR HIV CURE
MULTIDOSE IV ROMIDEPSIN: NO INCREASED HIV-1 EXPRESSION IN PERSONS ON ART, ACTG A5315   (ABSTRACT 26)
Deborah McMahon
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRATEGIES FOR HIV CURE
PEMBROLIZUMAB INDUCES HIV LATENCY REVERSAL IN HIV+ INDIVIDUALS ON ART WITH CANCER   (ABSTRACT 27)
Thomas S Uldrick
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRATEGIES FOR HIV CURE
POTENT ANTIVIRAL ACTIVITY OF TRISPECIFIC BROADLY NEUTRALIZING HIV ANTIBODIES   (ABSTRACT 28)
Amarendra Pegu
Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: STRATEGIES FOR HIV CURE
SUSTAINED HIV-1 REMISSION FOLLOWING HOMOZYGOUS CCR5 DELTA32 ALLOGENIC HSCT   (ABSTRACT 29)
Ravindra K Gupta
University College London, London, United Kingdom
from CROI 2019 on March 5, 2019 10:00 AM-12:00 PM
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
THEMED DISCUSSION LEADER
Blossom Damania
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
PRIMARY ROLE OF KSHV IN PATHOGENESIS OF ENDEMIC AND EPIDEMIC KAPOSI SARCOMA   (ABSTRACT 270)
Salum Juma Lidenge
University of Nebraska-Lincoln, Lincoln, NE, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
METABOLIC ABNORMALITIES IN CD8 T CELLS FROM HIV+ INDIVIDUALS WITH KAPOSI SARCOMA   (ABSTRACT 271)
Genevieve Tyndale Clutton
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
SINGLE CELL EVALUATION OF KAPOSI SARCOMA TUMORS REVEALS COMPLEX IMMUNE INFILTRATE   (ABSTRACT 272)
Warren Phipps
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
NEW VARIANT OF KAPOSI SARCOMA–ASSOCIATED HERPESVIRUS IN MEN WHO HAVE SEX WITH MEN   (ABSTRACT 273)
Aude Jary
AP–HP, Hôpitaux Universitaires Pitié Salpêtrière, Paris, France
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
QUESTIONS AND ANSWERS
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: LETS CHECK IN! NEW TOOLS FOR MONITORING ART AND PrEP ADHERENCE
THEMED DISCUSSION LEADER
Rodolphe Garraffo
Université de Nice-Sophia-Antipolis, Hôpital Pasteur, CHU de Nice, Nice, France
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: LETS CHECK IN! NEW TOOLS FOR MONITORING ART AND PrEP ADHERENCE
PI DRUG-LEVEL TESTING AS A SCREENING TOOL FOR DRUG RESISTANCE IN 2ND-LINE ART FAILURE   (ABSTRACT 461)
Lucas Etienne Hermans
University Medical Center Utrecht, Johannesburg, South Africa
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 88 from CROI 2019